Drugs that contain Ubrogepant

1. Drug name - UBRELVY

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US9499545 ALLERGAN Piperidinone carboxamide azaindane CGRP receptor antagonists
Nov, 2031

(9 years from now)

US8912210 ALLERGAN Piperidinone carboxamide azaindane CGRP receptor antagonists
Nov, 2031

(9 years from now)

US8754096 ALLERGAN Piperidinone carboxamide azaindane CGRP receptor antagonists
Jul, 2032

(9 years from now)

CN103328478A ALLERGAN Piperidones Carboxamide Indane Cgrp Receptor Antagonist
Nov, 2031

(9 years from now)

CN103328478B ALLERGAN Piperidone Carboxamide Nitrogen Mixed Indene Into Cgrp Receptor Antagonists
Nov, 2031

(9 years from now)

IN201303390P4 ALLERGAN Piperidinone Carboxamide Azaindane Cgrp Receptor Antagonists
Nov, 2031

(9 years from now)

IN289826B ALLERGAN Piperidinone Carboxamide Azaindane Cgrp Receptor Antagonists
Nov, 2031

(9 years from now)

EP2638042A1 ALLERGAN Piperidinone Carboxamide Azaindane Cgrp Receptor Antagonists
Nov, 2031

(9 years from now)

EP2821407B1 ALLERGAN Piperidinone Carboxamide Azaindane Cgrp Receptor Antagonists
Nov, 2031

(9 years from now)

EP2821407A1 ALLERGAN Piperidinone Carboxamide Azaindane Cgrp Receptor Antagonists
Nov, 2031

(9 years from now)

EP2638042B1 ALLERGAN Piperidinone Carboxamide Azaindane Cgrp Receptor Antagonists
Nov, 2031

(9 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9833448 ALLERGAN Piperidinone carboxamide azaindane CGRP receptor antagonists Nov, 2031

(9 years from now)

US10117836 ALLERGAN Tablet formulation for CGRP active compounds Jan, 2035

(12 years from now)

Treatment: Acute treatment of migraine with or without aura in adults

Dosage: TABLET;ORAL

More Information on Dosage
Strength Dosage Availability
50MG TABLET;ORAL Prescription
100MG TABLET;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.